Diagnosis of venous thromboembolic diseases in people with covid-19: summary of updated NICE guidance

What you need to knowThe current pathway for diagnosing pulmonary embolism or deep vein thrombosis, including the use of D-dimer testing, is appropriate for people with covid-19Prevention of primary venous thromboembolism in people with covid-19 should not be stopped, even if deep vein thrombosis or pulmonary embolism is not confirmedCriteria to rule out pulmonary embolism may not be suitable in people with covid-19 because of the increased risk of venous thromboembolism in this populationIn venous thromboembolism, a blood clot usually forms in the deep veins of the legs or pelvis. This is known as deep vein thrombosis, and the blood clot can dislodge from these sites, resulting in pulmonary embolism.In 2020, the National Institute for Health and Care Excellence (NICE) first published guidance on the diagnosis and management of venous thromboembolic disease.1 Since then, new evidence has emerged which indicates that people with covid-19 have a higher risk of developing…
Read Original Article: Diagnosis of venous thromboembolic diseases in people with covid-19: summary of updated NICE guidance »